Treace Medical Concepts, Inc. filings document the regulatory disclosures of a medical technology company focused on devices for bunion and related midfoot surgery. Its 8-K reports cover operating results, preliminary unaudited financial information, Regulation FD investor materials, press-release exhibits and Inline XBRL cover data.
The company’s SEC record also includes disclosures on material financing arrangements, including term loan and revolving loan agreements, as well as officer departures, board changes and committee matters. Proxy materials address annual meeting procedures, director elections, executive compensation, equity awards and corporate governance for the Delaware corporation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.92%
Tags
FAQ
How many TREACE MEDICAL CONCEPTS (TMCI) SEC filings are available on StockTitan?
StockTitan tracks 61 SEC filings for TREACE MEDICAL CONCEPTS (TMCI), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for TREACE MEDICAL CONCEPTS (TMCI)?
The most recent SEC filing for TREACE MEDICAL CONCEPTS (TMCI) was filed on August 7, 2025.